The Translational Research Initiative for Cell Engineering and Printing - TRICEP - works with research institutions and industry to develop innovative technologies using 3D bioprinting. TRICEP can commercialise opportunities in 3D bioprinting including printer manufacturing, biomaterials, bioinks, and material-cellular combinations to address significant industry challenges that require an exclusive, tailored solution. TRICEP’s world leading research infrastructure can assist companies to bring to life novel technology from concept stage through to prototyping and manufacture of hardware and the formulation of customised bioinks, to accelerate product development and rapidly decrease time to market. TRICEP is a 100% owned initiative of the University of Wollongong.